Table 1: Demographic and Clinical Characteristics - COPD - LAMA monotherapy
	Total	LABA/LAMA Combination	ICS Dual Combination	Other

1	  292,097 (100.0)	   79,581 (100.0)	   75,978 (100.0)	  136,538 (100.0)

Grouped age
1	    1,235 (0.4)	      151 (0.2)	      155 (0.2)	      929 (0.7)
2	   10,046 (3.4)	    1,931 (2.4)	    1,719 (2.3)	    6,396 (4.7)
3	   40,956 (14.0)	   10,502 (13.2)	    8,958 (11.8)	   21,496 (15.7)
4	   80,874 (27.7)	   22,895 (28.8)	   21,178 (27.9)	   36,801 (27.0)
5	  104,405 (35.7)	   29,628 (37.2)	   28,948 (38.1)	   45,829 (33.6)
6	   54,581 (18.7)	   14,474 (18.2)	   15,020 (19.8)	   25,087 (18.4)

Male
0	  133,885 (45.8)	   36,479 (45.8)	   35,594 (46.8)	   61,812 (45.3)
1	  158,212 (54.2)	   43,102 (54.2)	   40,384 (53.2)	   74,726 (54.7)

Grouped BMI
1	   11,366 (3.9)	    2,996 (3.8)	    3,265 (4.3)	    5,105 (3.7)
2	   89,275 (30.6)	   24,022 (30.2)	   22,912 (30.2)	   42,341 (31.0)
3	   95,543 (32.7)	   26,269 (33.0)	   24,547 (32.3)	   44,727 (32.8)
4	   55,582 (19.0)	   15,596 (19.6)	   14,689 (19.3)	   25,297 (18.5)
5	   22,082 (7.6)	    6,268 (7.9)	    5,955 (7.8)	    9,859 (7.2)
6	   10,018 (3.4)	    2,729 (3.4)	    2,778 (3.7)	    4,511 (3.3)
.	    8,231 (2.8)	    1,701 (2.1)	    1,832 (2.4)	    4,698 (3.4)

Smoking status
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)
2	  184,571 (63.2)	   47,774 (60.0)	   50,385 (66.3)	   86,412 (63.3)
3	  107,526 (36.8)	   31,807 (40.0)	   25,593 (33.7)	   50,126 (36.7)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)

Ethnicity
1	  219,008 (75.0)	   59,469 (74.7)	   57,577 (75.8)	  101,962 (74.7)
2	      676 (0.2)	      172 (0.2)	      138 (0.2)	      366 (0.3)
3	    3,369 (1.2)	      630 (0.8)	      685 (0.9)	    2,054 (1.5)
4	    1,210 (0.4)	      233 (0.3)	      243 (0.3)	      734 (0.5)
5	    1,061 (0.4)	      236 (0.3)	      251 (0.3)	      574 (0.4)
.	   66,773 (22.9)	   18,841 (23.7)	   17,084 (22.5)	   30,848 (22.6)

Index of Multiple Deprivation (IMD)
1	   58,944 (20.2)	   15,462 (19.4)	   14,544 (19.1)	   28,938 (21.2)
2	   58,848 (20.1)	   15,887 (20.0)	   15,006 (19.8)	   27,955 (20.5)
3	   59,247 (20.3)	   16,138 (20.3)	   15,523 (20.4)	   27,586 (20.2)
4	   57,682 (19.7)	   15,635 (19.6)	   15,784 (20.8)	   26,263 (19.2)
5	   57,376 (19.6)	   16,459 (20.7)	   15,121 (19.9)	   25,796 (18.9)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes Severity
1	  221,389 (75.8)	   60,251 (75.7)	   57,437 (75.6)	  103,701 (76.0)
2	   51,349 (17.6)	   14,089 (17.7)	   13,750 (18.1)	   23,510 (17.2)
3	   18,577 (6.4)	    5,049 (6.3)	    4,570 (6.0)	    8,958 (6.6)
4	      782 (0.3)	      192 (0.2)	      221 (0.3)	      369 (0.3)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)



Single SABA
0	  125,214 (42.9)	   25,709 (32.3)	   16,456 (21.7)	   83,049 (60.8)
1	  166,883 (57.1)	   53,872 (67.7)	   59,522 (78.3)	   53,489 (39.2)

High Dose ICS
0	  266,397 (91.2)	   79,581 (100.0)	   50,636 (66.6)	  136,180 (99.7)
1	   25,700 (8.8)	        0 (0.0)	   25,342 (33.4)	      358 (0.3)

Low/Medium Dose ICS
0	  204,825 (70.1)	   79,581 (100.0)	   22,648 (29.8)	  102,596 (75.1)
1	   87,272 (29.9)	        0 (0.0)	   53,330 (70.2)	   33,942 (24.9)

Single ICS
0	  284,779 (97.5)	   79,581 (100.0)	   75,030 (98.8)	  130,168 (95.3)
1	    7,318 (2.5)	        0 (0.0)	      948 (1.2)	    6,370 (4.7)

Single SAMA
0	  288,777 (98.9)	   79,299 (99.6)	   74,586 (98.2)	  134,892 (98.8)
1	    3,320 (1.1)	      282 (0.4)	    1,392 (1.8)	    1,646 (1.2)

Single LABA
0	  284,018 (97.2)	   77,148 (96.9)	   75,222 (99.0)	  131,648 (96.4)
1	    8,079 (2.8)	    2,433 (3.1)	      756 (1.0)	    4,890 (3.6)

Single LAMA
0	  204,395 (70.0)	   38,718 (48.7)	   31,374 (41.3)	  134,303 (98.4)
1	   87,702 (30.0)	   40,863 (51.3)	   44,604 (58.7)	    2,235 (1.6)

LABA ICS
0	  216,545 (74.1)	   79,581 (100.0)	      426 (0.6)	  136,538 (100.0)
1	   75,552 (25.9)	        0 (0.0)	   75,552 (99.4)	        0 (0.0)

LABA LAMA
0	  245,913 (84.2)	   38,204 (48.0)	   74,086 (97.5)	  133,623 (97.9)
1	   46,184 (15.8)	   41,377 (52.0)	    1,892 (2.5)	    2,915 (2.1)

LABA LAMA ICS
0	  259,057 (88.7)	   79,581 (100.0)	   71,081 (93.6)	  108,395 (79.4)
1	   33,040 (11.3)	        0 (0.0)	    4,897 (6.4)	   28,143 (20.6)

Single LTRA
0	  292,097 (100.0)	   79,581 (100.0)	   75,978 (100.0)	  136,538 (100.0)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)

Smoking status (missing set to non)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)

Chronic kidney disease
0	  242,158 (82.9)	   65,468 (82.3)	   62,937 (82.8)	  113,753 (83.3)
1	   49,939 (17.1)	   14,113 (17.7)	   13,041 (17.2)	   22,785 (16.7)

Diagnosed hypertension
0	  147,010 (50.3)	   39,379 (49.5)	   36,684 (48.3)	   70,947 (52.0)
1	  145,087 (49.7)	   40,202 (50.5)	   39,294 (51.7)	   65,591 (48.0)

Heart Failure
0	  267,454 (91.6)	   72,832 (91.5)	   69,036 (90.9)	  125,586 (92.0)
1	   24,643 (8.4)	    6,749 (8.5)	    6,942 (9.1)	   10,952 (8.0)

Other Heart Diseases
0	  226,533 (77.6)	   61,241 (77.0)	   58,889 (77.5)	  106,403 (77.9)
1	   65,564 (22.4)	   18,340 (23.0)	   17,089 (22.5)	   30,135 (22.1)

Cancer
0	  252,004 (86.3)	   68,423 (86.0)	   65,259 (85.9)	  118,322 (86.7)
1	   40,093 (13.7)	   11,158 (14.0)	   10,719 (14.1)	   18,216 (13.3)

Recent Statin
0	  150,591 (51.6)	   37,735 (47.4)	   37,145 (48.9)	   75,711 (55.5)
1	  141,506 (48.4)	   41,846 (52.6)	   38,833 (51.1)	   60,827 (44.5)

Flu vaccine
0	   73,937 (25.3)	   16,356 (20.6)	   14,861 (19.6)	   42,720 (31.3)
1	  218,160 (74.7)	   63,225 (79.4)	   61,117 (80.4)	   93,818 (68.7)

Pneumococcal Vaccine
0	  231,561 (79.3)	   59,861 (75.2)	   61,220 (80.6)	  110,480 (80.9)
1	   60,536 (20.7)	   19,720 (24.8)	   14,758 (19.4)	   26,058 (19.1)

Exacerbation in last year
0	  236,381 (80.9)	   65,033 (81.7)	   57,745 (76.0)	  113,603 (83.2)
1	   55,716 (19.1)	   14,548 (18.3)	   18,233 (24.0)	   22,935 (16.8)

Immunosuppressed (combination algorithm)
0	  291,348 (99.7)	   79,388 (99.8)	   75,803 (99.8)	  136,157 (99.7)
1	      749 (0.3)	      193 (0.2)	      175 (0.2)	      381 (0.3)

GP consultation count
Median (IQR)	9 (5-16)	10 (6-16)	10 (6-17)	9 (4-15)
Mean (SD)	12.214299 (11.719327)	12.460261 (11.460224)	13.018979 (12.141628)	. (.)	11.623167 (11.597111)
Min, Max	0, 510	0, 510	0, 306	0, 268
Exacerbation Count
Median (IQR)	0 (0-0)	0 (0-0)	0 (0-0)	0 (0-0)
Mean (SD)	.25912967 (.62488829)	.23635039 (.57125459)	.33988786 (.72166396)	. (.)	.22746781 (.59197527)
Min, Max	0, 12	0, 9	0, 12	0, 10
Age (years)
Median (IQR)	71 (63-77)	71 (63-77)	71 (64-78)	70 (61-77)
Mean (SD)	69.759912 (10.765677)	70.129151 (10.143299)	70.7362 (10.157993)	. (.)	69.001435 (11.374375)
Min, Max	35, 103	35, 102	35, 102	35, 103
